Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion type Assertion NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_head.
- NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion description "[No differences in percentage S-phase cells or multidrug resistance transporter (MDR1 or BCRP) expression or function were observed in vivo in leukemia blasts upon vorinostat treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_provenance.
- NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion evidence source_evidence_literature NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_provenance.
- NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion SIO_000772 23403629 NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_provenance.
- NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion wasDerivedFrom befree-2016 NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_provenance.
- NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_assertion wasGeneratedBy ECO_0000203 NP1052380.RAt6Yhg8Lk40CMvnRKuthZYAFL2Sijsfh3wVjc9pjKT_Q130_provenance.